Envestnet Asset Management Inc Zai Lab LTD Transaction History

Envestnet Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$27.77 - $64.4 $104,831 - $243,110	-3,775 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$54.9 - $105.21 $9,772 - $18,727	178 Added 4.95%	3,775 $237,000
Q3 2021 Oct 07, 2021	BUY	$105.0 - $178.37 $67,095 - $113,978	639 Added 21.6%	3,597 $379,000
Q2 2021 Aug 04, 2021	BUY	$125.11 - $180.0 $8,882 - $12,780	71 Added 2.46%	2,958 $524,000
Q1 2021 May 04, 2021	BUY	$126.27 - $191.71 $120,335 - $182,699	953 Added 49.28%	2,887 $385,000
Q4 2020 Feb 02, 2021	BUY	$81.94 - $135.34 $158,471 - $261,747	1,934 New	1,934 $262,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.95B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.